A stronger Ozempic is coming. What to know about CagriSema, Novo Nordisk's new weight loss drug

Novo Nordisk (NVO) — the company credited with ushering in the current weight-loss drug revolution when it launched its blockbuster diabetes treatment Ozempic in 2017 — is working on its next act, a weight-loss drug called CagriSema